RESUMEN
This study reports the results of a systematic screening for respiratory viruses in pediatric outpatients from an emergency department (ED) in southern Brazil during two consecutive influenza seasons. Children eligible for enrollment in this study were aged 24-59 months and presented with acute respiratory symptoms and fever. Naso- and oropharyngeal swabs were collected and multiplex reverse transcription PCR (RT-PCR) was performed to identify the respiratory viruses involved. In total, 492 children were included in this study: 248 in 2010 and 244 in 2011. In 2010, 136 samples (55%) were found to be positive for at least one virus and the most frequently detected viruses were human rhinovirus (HRV) (18%), adenovirus (AdV) (13%), and human coronavirus (CoV) (5%). In 2011, 158 samples (65%) were found to be positive for at least one virus, and the most frequently detected were HRV (29%), AdV (12%), and enterovirus (9%). Further, the presence of asthma (OR, 3.17; 95% CI, 1.86-5.46) was independently associated with HRV infection, whereas fever was associated with AdV (OR, 3.86; 95% CI, 1.31-16.52) and influenza infections (OR, 3.74; 95% CI, 1.26-16.06). Ten patients (2%) were diagnosed with pneumonia, and six of these tested positive for viral infection (4 HRV, 1 RSV, and 1 AdV). Thus, this study identified the most common respiratory viruses found in preschool children in the study region and demonstrated their high frequency, highlighting the need for improved data collection, and case management in order to stimulate preventive measures against these infections. J. Med. Virol. 88:1325-1333, 2016. © 2016 Wiley Periodicals, Inc.
Asunto(s)
Gripe Humana/epidemiología , Infecciones del Sistema Respiratorio/epidemiología , Virosis/epidemiología , Virus/aislamiento & purificación , Adenoviridae/genética , Adenoviridae/aislamiento & purificación , Infecciones por Adenoviridae/epidemiología , Infecciones por Adenoviridae/prevención & control , Infecciones por Adenoviridae/virología , Brasil/epidemiología , Niño , Preescolar , Femenino , Humanos , Lactante , Virus de la Influenza A/genética , Virus de la Influenza A/aislamiento & purificación , Gripe Humana/virología , Masculino , Reacción en Cadena de la Polimerasa Multiplex , Nariz/virología , Orofaringe/virología , Pacientes Ambulatorios , Infecciones por Virus Sincitial Respiratorio/epidemiología , Infecciones por Virus Sincitial Respiratorio/prevención & control , Infecciones por Virus Sincitial Respiratorio/virología , Virus Sincitiales Respiratorios/genética , Virus Sincitiales Respiratorios/aislamiento & purificación , Infecciones del Sistema Respiratorio/prevención & control , Infecciones del Sistema Respiratorio/virología , Rhinovirus/genética , Rhinovirus/aislamiento & purificación , Estaciones del Año , Virosis/diagnóstico , Virosis/prevención & control , Virosis/virología , Virus/clasificación , Virus/genéticaRESUMEN
In August 27/2014, SLIPE organized the Master Class "Towards improved influenza control through vaccination", a panel with international influenza experts who shared their understanding of the disease and the control measures available, focusing on the most recent information about this serious diseases. In this report Dr Falleiros and Dr Bricks summarized the following topics: Global influenza epidemiology, presented by Dr Puig-Barbera; Influenza vaccine recommendations and coverage in Latin American countries, presented by Dr Bricks; Influenza vaccines efficacy and effectiveness, presented by Dr Fedson: Influenza burden ;md rational for prevention in children, presented by Dr Muiioz; Influenza burden in pregnancy, presented by Dr Ribeiro; Influenza vaccination in health care workers, presented by Dr Macias; Influenza vaccination in the elderly, presented by Dr Ribeiro; Rational to increase vaccination coverage rates Global Influenza Hospital Surveillance Network, presented by Dr Puig-Barbera; Influenza B epidemiology and vaccine strain mismatch in Latin American Region, presented by Dr Bricks; Modeling for quadrivalent influenza vaccines impact, presented by Dr Blank; Rational for quadrivalent influenza vaccines and the clinical development of QIV s, presented by Dr Desauziers and Modelling quadrivalent influenza vaccines impact, presented by Dr Blank.
Asunto(s)
Vacunas contra la Influenza/administración & dosificación , Gripe Humana/prevención & control , Anciano , Niño , Femenino , Humanos , América Latina , EmbarazoRESUMEN
During 2010, outbreaks of serogroup C meningococcal (MenC) disease occurred in 2 oil refineries in São Paulo State, Brazil, leading to mass vaccination of employees at 1 refinery with a meningococcal polysaccharide A/C vaccine. A cross-sectional study was conducted to assess the prevalence of meningococci carriage among workers at both refineries and to investigate the effect of vaccination on and the risk factors for pharyngeal carriage of meningococci. Among the vaccinated and nonvaccinated workers, rates of overall meningococci carriage (21.4% and 21.6%, respectively) and of MenC carriage (6.3% and 4.9%, respectively) were similar. However, a MenC strain belonging to the sequence type103 complex predominated and was responsible for the increased incidence of meningococcal disease in Brazil. A low education level was associated with higher risk of meningococci carriage. Polysaccharide vaccination did not affect carriage or interrupt transmission of the epidemic strain. These findings will help inform future vaccination strategies.
Asunto(s)
Portador Sano/epidemiología , Meningitis Meningocócica/clasificación , Infecciones Meningocócicas/epidemiología , Infecciones Meningocócicas/prevención & control , Vacunas Meningococicas/inmunología , Adolescente , Adulto , Brasil/epidemiología , Estudios Transversales , Brotes de Enfermedades , Historia del Siglo XXI , Humanos , Incidencia , Meningitis Meningocócica/genética , Meningitis Meningocócica/inmunología , Infecciones Meningocócicas/historia , Tipificación de Secuencias Multilocus , Factores de Riesgo , Serotipificación , Vacunación , Adulto JovenRESUMEN
Introduction: Pertussis in Latin America continues to cause periodic epidemics with substantial morbidity particularly among young children. The disease has persisted despite long-standing vaccination programs in the region. Areas covered: We conducted a systematic review to characterize the recent epidemiology of pertussis in Latin America and Hispanic Caribbean. We undertook a holistic approach and attempted to include all available data concerning pertussis that may explain the changing dynamics of the disease. Expert opinion: There are wide disparities in the reported annual incidence rates of pertussis both within and between countries in the region. General trends in pertussis incidence are difficult to ascertain due to the heterogeneity in the epidemiological data. Available data suggests that the disease burden has changed over the years such that now it predominantly affects those <1 year. Coverage with three doses of the pertussis vaccine has been highly variable, and very few countries have consistently achieved ≥90% coverage annually since 2000. There remain inequalities in vaccination coverage in some regions/localities and specific groups, which sustains the risk of pertussis dissemination. The WHO considers that maternal pertussis immunization provides protection to infants too young to be vaccinated; >10 Latin American countries currently recommend vaccination of pregnant women.
Asunto(s)
Vacuna contra la Tos Ferina/administración & dosificación , Vacunación/estadística & datos numéricos , Tos Ferina/prevención & control , Región del Caribe/epidemiología , Femenino , Humanos , Incidencia , Lactante , América Latina/epidemiología , Vacuna contra la Tos Ferina/inmunología , Embarazo , Cobertura de Vacunación , Tos Ferina/epidemiología , Tos Ferina/inmunologíaRESUMEN
UNLABELLED: Sinusitis, acute otitis media and tonsillitis are very frequent in children. Most of these infections are caused by viruses, but are generally treated with antibiotics. Inappropriate use of antibiotics favors the selection, growth and spread of resistant bacteria; these bacteria colonize the airways and affect the entire community. With the emergence of antibiotic-resistant bacteria, respiratory infections have become more difficult to treat. Effective strategies are needed to restrict the use of antibiotics without harming children that truly need these drugs. AIM: to present a critical analysis of the results of randomized and controlled studies on clinical and laboratory criteria used in diagnosing and treating tonsillitis, sinusitis and otitis. METHODS: a review of randomized and controlled studies about these conditions published in MEDLINE and SCIELO from 2000 to 2006. CONCLUSIONS: Given that most of these infections progress favorably without antibiotics, the use of these drugs should be avoided unless the child belongs to a high risk group for complications, or symptoms persist or worsen with despite symptomatic treatment. Physicians and laypersons should have better knowledge about the natural evolution of acute respiratory infections.
Asunto(s)
Otitis Media/terapia , Sinusitis/terapia , Tonsilitis/terapia , Enfermedad Aguda , Antibacterianos/uso terapéutico , Niño , Farmacorresistencia Microbiana , Humanos , Otitis Media/diagnóstico , Guías de Práctica Clínica como Asunto , Ensayos Clínicos Controlados Aleatorios como Asunto , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/terapia , Sinusitis/diagnóstico , Tonsilitis/diagnósticoRESUMEN
OBJECTIVE: To verify how reliable is the information provided by parents about the history of varicella in their children. METHODS: 204 parents of previously healthy children attending two municipal day-care centers of São Paulo city were interviewed between August 2003 and September 2005. A standardized form was filled out with information regarding age, sex, history of varicella and other diseases, drug use and antecedent of immunization, After medical history, physical examination and checking of immunization records, 5 ml of blood were collected for ELISA (in house) varicella test. Exclusion criteria were: age less than 1 year or more than 60 months, previous immunization against chickenpox, presence of co-morbidities or recent use of immunosuppressive drugs. Data were filed in a data bank using the Excel 2003 Microsoft Office Program and stored in a PC computer. The exact Fisher test was employed to calculate sensibility, specificity, positive and negative predictive values of history of varicella informed by children's parents. RESULTS: The age of the children varied from 12 to 54 months (median, 26 months; 49 (24%) children had positive history of varicella, 155 (76%) a negative or doubtful history. The predictive positive and negative values of the information were 90% and 93%, respectively (p = 0.0001). CONCLUSIONS: The degree of reliability of information about history of varicella informed by parents of children attending day care centers was high and useful to establish recommendations on varicella blocking immunization in day-care centers.
Asunto(s)
Anticuerpos Antivirales/sangre , Varicela/inmunología , Guarderías Infantiles/estadística & datos numéricos , Herpesvirus Humano 3/inmunología , Brasil , Varicela/sangre , Preescolar , Estudios Transversales , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Lactante , Masculino , Valor Predictivo de las Pruebas , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Encuestas y CuestionariosRESUMEN
Annual trivalent influenza vaccines (TIV) containing 2 A strains and one B lineage have been recommended for the prevention of influenza in most of Latin American countries. However, the circulation of 2 B lineages (Victoria and Yamagata) and difficulties in predicting the predominating lineage have led to the development of quadrivalent influenza vaccines (QIV), including both B lineages. Thus, the objective was to estimate the public health impact and influenza-related costs if QIV would have been used instead of TIV in 3 Latin American countries. We used a static model over the seasons 2010-2014 in Brazil, 2007-2014 in Colombia and 2006-2014 in Panama, focusing on population groups targeted by local vaccination recommendations: young children, adults with risk factors and the elderly. In Brazil, between 2010 and 2014, using QIV instead of TIV would have avoided US$ 6,200 per 100,000 person-years in societal costs, based on 168 influenza cases, 89 consultations, 3.2 hospitalizations and 0.38 deaths per 100,000 person-years. In Colombia and Panama, these would have ranged from US$ 1,000 to 12,700 (based on 34 cases, 13-25 consultations, 0.6-8.9 hospitalizations and 0.04-1.74 deaths) and from US$ 3,000 to 33,700 (based on 113 cases, 55-82 consultations, 0.5-27.8 hospitalizations and 0.08-6.87 deaths) per 100,000 person-years, respectively. Overall, the broader protection offered by QIV would have reduced the influenza humanistic and economic burden in the 3 countries. Despite the lack of local data leading to several extrapolations, this study is the first to give quantitative estimates of the potential benefits of QIV in Latin America.
Asunto(s)
Costos de la Atención en Salud , Vacunas contra la Influenza/administración & dosificación , Vacunas contra la Influenza/inmunología , Gripe Humana/epidemiología , Gripe Humana/prevención & control , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Brasil/epidemiología , Niño , Preescolar , Colombia/epidemiología , Humanos , Lactante , Vacunas contra la Influenza/economía , Gripe Humana/economía , Persona de Mediana Edad , Panamá/epidemiología , Adulto JovenRESUMEN
OBJECTIVE: To describe morbidity associated to varicella in children attending day care centers. METHODS: Descriptive study carried out through inquiries with parents of 664 children who acquired varicella after admission to day care centers in Taubaté (population: 244,165, census of 2004), a prosperous city in the State of São Paulo. RESULTS: The median age was 36 months (range 6 to 80 months); 8.4% of the children had varicella before 1 year of age. The main symptoms were: exanthema (100.0%), fever (85.4%) anorexia (39.6%), and headache (15.3%). 517 children (77.9%) had at least 1 medical visit, and 80.6% received at least 1 medication; 73 (11.0%) received nonsteroidal antiinflammatory drugs, and 52 (7.8%) received antibiotics. Complications occurred in 38 children (5.7%; 95% confidence interval: 3% - 8%); 8 (1.2%) were hospitalized, and 5 (0.7%) had sequelae. Complications and hospitalizations rates were 3 times more frequent in children with less than 1 year of age than in older children. More than half of the children and of the working parents were absent from their regular activities for more than a week. CONCLUSIONS: Varicella was associated with significant morbidity, affected younger children, was complicated in more than 5%, and left sequelae in 0.7% of children. More than 10% of the children received nonsteroidal antiinflammatory drugs, highlighting the need to warn the population about the risks of these drugs. Although varicella vaccination is not recommended for children younger than 12 months, vaccination of the children older than a year could avoid by herd immunity the transmission to babies. Brazilian public health authorities should be alerted to this issue and offer varicella vaccine to children attending day care centers.
Asunto(s)
Varicela/epidemiología , Guarderías Infantiles/estadística & datos numéricos , Brasil/epidemiología , Varicela/complicaciones , Varicela/inmunología , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , MorbilidadRESUMEN
OBJECTIVES: To evaluate the impact of heptavalent pneumococcal conjugate vaccine in invasive pneumococcal diseases in the United States, and to analyze the potential impact of this vaccine in Brazil. SOURCES OF DATA: MEDLINE, LILACS, Cochrane Database Reviews, as well as the websites of the Centers for Disease Control and Prevention (CDC), Brazilian Ministry of Health and Centro de Vigilância Epidemiológica do Estado de São Paulo from January 2000 to January 2006. Articles retrieved with the keywords Streptococcus pneumoniae, pneumococcal diseases, conjugate vaccine, antimicrobial resistance and meningitis were reviewed. SUMMARY OF THE FINDINGS: The introduction of heptavalent pneumococcal conjugate vaccine caused a dramatic reduction in the incidence of invasive pneumococcal diseases in American children, reduced antibiotic use and the number of medical visits due to otitis media and pneumonia by children. The incidence of invasive pneumococcal diseases caused by resistant strains declined in immunized children, adults and elderly individuals. In Brazil, the mortality rate of pneumococcal meningitis is very high and the resistance to antibiotics has increased over the last 5 years. CONCLUSIONS: Heptavalent pneumococcal conjugate vaccine can benefit not only children, but the entire community and should be included in the Brazilian routine immunization schedule.
Asunto(s)
Vacunas Meningococicas/uso terapéutico , Infecciones Neumocócicas/prevención & control , Vacunas Neumococicas/uso terapéutico , Adulto , Brasil , Niño , Preescolar , Farmacorresistencia Bacteriana , Vacuna Neumocócica Conjugada Heptavalente , Humanos , Esquemas de Inmunización , Vacunas Meningococicas/economía , Vacunas Meningococicas/normas , Persona de Mediana Edad , Infecciones Neumocócicas/complicaciones , Vacunas Neumococicas/economía , Vacunas Neumococicas/normas , Vacunas Conjugadas/economía , Vacunas Conjugadas/normas , Vacunas Conjugadas/uso terapéuticoRESUMEN
OBJECTIVES: To present an up-to-date review of studies investigating the efficacy, adverse events and vaccination regimens of the varicella vaccine and the new presentation combined with the vaccine for measles, mumps and rubella. SOURCES OF DATA: Bibliographic review of the MEDLINE and LILACS databases covering the period 1999 to 2006. SUMMARY OF THE FINDINGS: The varicella vaccine protects 70 to 90% of immunized children against any form of varicella zoster infection, but the efficacy against severe forms is higher (95 to 98%). This is a well-tolerated vaccine that causes few reactions. Since the vaccine was licensed, there have been three confirmed cases of transmission of the vaccine virus by domestic contacts to previously healthy people, who went on to develop mild disease. Despite evidence that the protection offered by this vaccine can wane over a number of years, it is not yet possible to state that a second dose is warranted, bearing in mind exposure to wild virus. After universal vaccination the chances of natural stimulation should drop and it is very probable that booster doses will become necessary. A measles, mumps, rubella, and varicella vaccine has recently been licensed that combines vaccines for measles, mumps, rubella and varicella in a single product with high rates of seroconversion. CONCLUSIONS: The Brazilian Society of Pediatrics recommends the varicella vaccine for children from 1 year on. We hope that the measles, mumps, rubella, and varicella vaccine will soon be available in Brazil, since combined vaccines facilitate wider vaccination coverage.
Asunto(s)
Vacuna contra la Varicela/uso terapéutico , Esquemas de Inmunización , Vacuna contra el Sarampión-Parotiditis-Rubéola/uso terapéutico , Vacunación/normas , Virosis/prevención & control , Brasil , Varicela/prevención & control , Vacuna contra la Varicela/efectos adversos , Humanos , Inmunización Secundaria , Vacunación Masiva , Sarampión/prevención & control , Vacuna contra el Sarampión-Parotiditis-Rubéola/efectos adversos , Paperas/prevención & control , Rubéola (Sarampión Alemán)/prevención & control , Vacunas Combinadas , Virosis/inmunologíaRESUMEN
OBJECTIVE: To perform a bibliographic review on criterion-based use of drugs by children. SOURCES: Articles were searched through Medline database using the terms: acute respiratory diseases, asthma, antibiotics, treatment and children. SUMMARY OF THE FINDINGS: There is an excessive use of drugs to treat acute respiratory diseases and asthma. Drugs with unproved action are frequently prescribed. CONCLUSIONS: Considering the toxicity of many drugs used in children and the emergency of bacterial strains resistant to antibiotics, it is essential to develop new methods of diagnosing bacterial infections, as well as to educate both physicians and the general public on the judicious use of drugs.
Asunto(s)
Utilización de Medicamentos/normas , Antibacterianos/uso terapéutico , Asma/tratamiento farmacológico , Niño , Humanos , Infecciones del Sistema Respiratorio/tratamiento farmacológicoRESUMEN
OBJECTIVE: To compare the intradermal and percutaneous routes of BCG administration. SOURCES OF DATA: A review of the literature published between 1987 and 2002 was carried out in the MEDLINE and Lilacs databases. The following key words were used: BCG vaccine/administration, adverse effects, efficacy, tuberculosis/prevention and control. Some articles published before 1987 were included because of their relevance to the topic. SUMMARY OF THE FINDINGS: There are no clinical studies comparing the efficacy of intradermal and percutaneous BCG. Percutaneous BCG causes a weaker reaction, however it is also less efficient in stimulating gamma-interferon production by Th1-lymphocytes, which is considered as the best marker of the anti-tuberculin immune response. CONCLUSIONS: In vivo and in vitro studies suggest a better immune response with intradermal BCG. The intradermal method should be recommended for BCG administration.
Asunto(s)
Vacuna BCG/administración & dosificación , Tuberculosis/prevención & control , Administración Cutánea , Vacuna BCG/efectos adversos , Humanos , Pruebas Inmunológicas , Inyecciones Intradérmicas , Tuberculosis/inmunologíaRESUMEN
OBJECTIVE: Streptococcus pneumoniae usually colonizes the oropharynx of healthy people. Oropharyngeal carriage is related to the invasion of adjacent structures and to the development of invasive disease. A descriptive cross-sectional study was performed aiming at verifying the prevalence of oropharyngeal colonization by S. pneumoniae in children attending day care centers in the city of Taubaté - SP; verifying the frequency of S. pneumoniae serotypes in isolated strains; and relating the most frequent serotypes to the composition of the conjugated heptavalent pneumococcal vaccine currently in use. METHODS: From June 29 to December 15 1998, samples of oropharyngeal material were collected from 987 children, ranging from 8 to 71 months old, enrolled in day care centers in Taubaté - SP. The identification of S. pneumoniae was based on the observation of the colonies that presented partial hemolysis in agar-blood and agar-blood with gentamycin plates and on the observation of inhibited growth around the optochin disc. Serotyping was performed by the Quellung reaction, using specific antiserum, provided by the Centers for Disease Control and Prevention (Atlanta, GA/USA), and the Danish nomenclature system. RESULTS: S. pneumoniae was isolated from the oropharynx in 209 out of 987 children (colonization rate of 21.2%). Twenty eight serotypes were identified. The seven most frequent serotypes were: 6A/6B (21.5%), 19F (14.8%), 18C (7.4%), 23F (7.4%), 9V (6.7%), 14 (5.2%), 10A (4.4%). Except for serotype 10A, all the other six are included in the vaccine. The only vaccine serotype which was not found was serotype 4. CONCLUSION: Agreement of 63% between the oropharynx colonizer serotypes and the serotypes present in the vaccine was found.
Asunto(s)
Orofaringe/microbiología , Streptococcus pneumoniae/aislamiento & purificación , Brasil , Preescolar , Femenino , Vacuna Neumocócica Conjugada Heptavalente , Humanos , Lactante , Masculino , Vacunas Meningococicas , Vacunas Neumococicas , Serotipificación , Streptococcus pneumoniae/clasificaciónRESUMEN
Household contacts are important sources of Bordetella pertussis in infants. A total of 353 household contacts of 97 index cases were evaluated for pertussis by culture and polymerase chain reaction. Twenty eight contacts were positive (8.0%). The presence of symptoms did not influence the rate of diagnosed bacteriologic pertussis in communicants. We conclude that contacts with an index case can be positive for B. pertussis independently of the presence of symptoms.
Asunto(s)
Bordetella pertussis/aislamiento & purificación , Composición Familiar , Salud de la Familia , Tos Ferina/epidemiología , Técnicas Bacteriológicas , Bordetella pertussis/genética , Bordetella pertussis/crecimiento & desarrollo , Brasil/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Reacción en Cadena de la Polimerasa , Prevalencia , Estudios Prospectivos , Tos Ferina/microbiología , Tos Ferina/transmisiónRESUMEN
The aim of this study was to describe recent changes in the epidemiology of pertussis and existing policies regarding recommended and mandatory occupational vaccinations for healthcare professionals (HCPs). The authors carried out an extensive review of references on the PubMed and SciELO databases and the official sites of the World Health Organization, Pan American Health Organization, Centers for Disease Control and Prevention, and Brazilian Ministry of Health, using the keywords pertussis, vaccines and healthcare professionals. Vaccination against pertussis is recommended for HCPs in the United States, Canada, nine European countries, Australia, Hong Kong, Singapore, Costa Rica, Argentina and Uruguay, and in some countries it is compulsory. In Brazil, only one publication discussing the risk of pertussis among HCPs was found. Considering the reemergence of pertussis and the great number of associated hospitalizations and deaths registered in 2011, it is necessary to review public policies regarding HCP pertussis vaccination, particularly among workers in frequent contact with young babies.
Asunto(s)
Vacunas contra Difteria, Tétanos y Tos Ferina Acelular , Personal de Salud , Transmisión de Enfermedad Infecciosa de Profesional a Paciente/prevención & control , Tos Ferina/transmisión , Adulto , Vacuna contra Difteria, Tétanos y Tos Ferina/inmunología , Vacunas contra Difteria, Tétanos y Tos Ferina Acelular/inmunología , Humanos , Esquemas de Inmunización , Persona de Mediana Edad , Vacunación , Tos Ferina/epidemiología , Tos Ferina/inmunología , Tos Ferina/prevención & control , Adulto JovenRESUMEN
UNLABELLED: A literature survey and analysis was conducted to describe the epidemiology of dengue disease in Brazil reported between 2000 and 2010. The protocol was registered on PROSPERO (CRD42011001826: http://www.crd.york.ac.uk/prospero/display_record.asp?ID=CRD42011001826). Between 31 July and 4 August 2011, the published literature was searched for epidemiological studies of dengue disease, using specific search strategies for each electronic database. A total of 714 relevant citations were identified, 51 of which fulfilled the inclusion criteria. The epidemiology of dengue disease in Brazil, in this period, was characterized by increases in the geographical spread and incidence of reported cases. The overall increase in dengue disease was accompanied by a rise in the proportion of severe cases. The epidemiological pattern of dengue disease in Brazil is complex and the changes observed during this review period are likely to have been influenced by multiple factors. Several gaps in epidemiological knowledge regarding dengue disease in Brazil were identified that provide avenues for future research, in particular, studies of regional differences, genotype evolution, and age-stratified seroprevalence. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration number: CRD42011001826.
Asunto(s)
Dengue/epidemiología , Brasil/epidemiología , Dengue/patología , Humanos , Incidencia , Topografía MédicaAsunto(s)
Virus de la Influenza B/inmunología , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/epidemiología , Gripe Humana/prevención & control , Adolescente , Adulto , Niño , Preescolar , Carga Global de Enfermedades , Humanos , Vacunas contra la Influenza/inmunología , América Latina/epidemiologíaRESUMEN
El 27 de agosto de 2014, la Sociedad Latinoamericana de Infectología Pediátrica (SLIPE) organizó la Conferencia Magistral sobre el tema "Hacia un Mejor Control de la Influenza mediante la Vacunación", un panel con especialistas internacionales en influenza, quienes compartieron su respectiva comprensión de la enfermedad y de las medidas de control disponibles, focalizando las informaciones más recientes sobre esta grave afección. En su informe, las Dras. Falleiros y Bricks resumieron los siguientes temas: Epidemiología global de la influenza, presentado por el Dr. Puig-Barbera; Recomendaciones sobre la vacuna contra la influenza y cobertura en los países de América Latina, presentado por la Dra. Bricks; Eficacia y efectividad de las vacunas contra la influenza, presentado por el Dr. Fedson; Impacto de la influenza y razones para la prevención en niños, presentado por el Dr. Muñoz; Efecto de la influenza en la gravidez, presentado por el Dr. Ribeiro; Vacunación contra la influenza en personal dedicado a cuidados de la salud, presentado por el Dr. Macías; Vacunación contra la influenza en los ancianos, presentado por el Dr. Ribeiro; Razones para aumentar las tasas de cobertura de la vacunación, Red Global de Vigilancia de la influenza en hospitales, presentado por el Dr. Puig-Barbera; Epidemiología de la influenza B y no equiparación de cepas de vacunas en la Región de América Latina, presentado por la Dra. Bricks; Modelaje para el impacto de las vacunas cuadrivalentes contra la influenza, presentado por el Dr. Blank; Razones de las vacunas cuadrivalentes contra la influenza y desarrollo clínico de QIVs, presentado por el Dr. Desauziers.
Asunto(s)
Humanos , Femenino , Embarazo , Niño , Anciano , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/prevención & control , América LatinaRESUMEN
The aim of this study was to describe recent changes in the epidemiology of pertussis and existing policies regarding recommended and mandatory occupational vaccinations for healthcare professionals (HCPs). The authors carried out an extensive review of references on the PubMed and SciELO databases and the official sites of the World Health Organization, Pan American Health Organization, Centers for Disease Control and Prevention, and Brazilian Ministry of Health, using the keywords pertussis, vaccines and healthcare professionals. Vaccination against pertussis is recommended for HCPs in the United States, Canada, nine European countries, Australia, Hong Kong, Singapore, Costa Rica, Argentina and Uruguay, and in some countries it is compulsory. In Brazil, only one publication discussing the risk of pertussis among HCPs was found. Considering the reemergence of pertussis and the great number of associated hospitalizations and deaths registered in 2011, it is necessary to review public policies regarding HCP pertussis vaccination, particularly among workers in frequent contact with young babies.
O objetivo deste artigo é descrever as recentes mudanças na epidemiologia da pertússis e as políticas de vacinação voltadas à prevenção da coqueluche para profissionais de saúde. Os autores fizeram um levantamento dos artigos publicados no PubMed, SciELO e páginas da Internet da Organização Mundial da Saúde, Organização Pan-Americana da Saúde, Centers for Disease Control and Prevention (Estados Unidos) e do Ministério da Saúde usando as palavras-chave: pertussis, vacinas e profissionais de saúde. A vacinação de profissionais de saúde contra coqueluche é recomendada pela OMS, OPAS, CDC, e autoridades de saúde de nove países europeus, da Austrália, Hong Kong, Cingapura, Costa Rica, Argentina e Uruguai, e em alguns países é compulsória. No Brasil, identificamos apenas um artigo abordando a vacinação de profissionais de saúde contra coqueluche, mas considerando a reemergencia da doença com grande número de hospitalizações e mortes em 2011, consideramos necessário rediscutir as políticas públicas envolvendo a vacinação dos profissionais de saúde, particularmente daqueles que têm contato frequente com lactentes jovens.
El propósito de este artículo es describir los recientes cambios en la epidemiología y políticas de vacunación para la prevención de la tos ferina en los profesionales de la salud. Los autores realizaron un estudio de los artículos publicados en PubMed, sitios como SciELO, de la OMS, OPS, CDC y Ministerio de Salud de Brasil con las siguientes palabras clave: vacunas contra la tos ferina y profesionales de la salud. La vacunación de los trabajadores de la salud contra la tos ferina es recomendada por la OMS, la OPS, CDC y por las autoridades sanitarias de 9 países europeos, de Australia, Hong Kong, Singapur, Costa Rica, Argentina y Uruguay, y en algunos países es obligatoria. En Brasil, se ha identificado un solo artículo sobre la vacunación de los trabajadores de la salud contra la tos ferina, sin embargo, frente al resurgimiento de la enfermedad con un gran número de hospitalizaciones y muertes en 2011, consideramos que es necesario revisar la política pública de vacunación de los profesionales de la salud, especialmente si tienen contacto con niños pequeños.